Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|November 22, 2014
Biological evaluation of a novel sorafenib analogue, t-CUPMAaron T Wecksler, Sung Hee Hwang, Jun-Yan Liu, et al.Plos One|January 30, 2014
Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environmentKyoungmi Kim, Christine Mall, Sandra L Taylor, et al.Journal of Cardiovascular Pharmacology|September 16, 2008
Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse modelArzu Ulu, Benjamin B Davis, Hsing-Ju Tsai, et al.The Journal of Urology|December 13, 2006
p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approachesRobert H Weiss, Alexander D Borowsky, David Seligson, et al.Cancer Research|May 26, 2012
Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysisSheila Ganti, Sandra L Taylor, Omran Abu Aboud, et al.American Journal of Physiology. Renal Physiology|July 10, 2015
The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarateVicki J Hwang, Jeffrey Kim, Amy Rand, et al.Oncogene|October 17, 2019
Targeting the vasopressin type-2 receptor for renal cell carcinoma therapySonali Sinha, Nidhi Dwivedi, Shixin Tao, et al.Plos One|November 9, 2013
Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acidsMalin L Nording, Jun Yang, Katrin Georgi, et al.Scientific Reports|March 8, 2020
A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cellsRosita R Asawa, Carina Danchik, Alexey Zakharov, et al.Metabolomics : Official Journal of the Metabolomic Society|July 9, 2013
Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterationsAngela M Zivkovic, Jun Yang, Katrin Georgi, et al.Pageof 10